
OssDsign
Develops implants for bone replacement.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 Valuation: €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | N/A | Secondary |
Total Funding | 000k |












EUR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 28 % | 80 % | 97 % | 19 % | 36 % | 28 % | 27 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (252 %) | (141 %) | (91 %) | (37 %) | (18 %) | (7 %) | 1 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (296 %) | (174 %) | (116 %) | (37 %) | (22 %) | (10 %) | (1 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | - | 45 % | 26 % | 17 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
OssDsign AB is a pioneering company specializing in the design and manufacture of implants and material technology for bone regeneration, particularly in cranioplasty and facial reconstructive surgery. The company operates in the medical device market, serving neurosurgeons, craniofacial surgeons, and patients requiring cranial and facial bone repair. OssDsign's business model revolves around leveraging clinical insights and proprietary material technology to create patient-specific, tailored solutions that enhance healing and regeneration. The company generates revenue through the sale of its innovative implants and related technologies, which are developed in collaboration with clinical researchers at Karolinska University Hospital and material science experts at Uppsala University. OssDsign's products are designed to improve surgical outcomes and patient recovery times, making them a valuable asset in the medical field.
Keywords: cranial repair, facial reconstruction, bone regeneration, medical implants, proprietary technology, patient-specific design, neurosurgery, cranioplasty, clinical collaboration, material science.
Tech stack
Investments by OssDsign
Edit